Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:07 AM
Ignite Modification Date:
2025-12-25 @ 2:07 AM
NCT ID:
NCT00600860
Eligibility Criteria:
Inclusion Criteria:
Patients must meet all of the following criteria
* Age \> 18 years
* Newly diagnosed patient (within 100 days from the date of the diagnostic bone marrow (BM) aspirate)
* MDS classified according to current WHO criteria
* All sub groups of MDS
* Therapy-related MDS
* MDS with Fibrosis (MDS-F)
* AML with 20-\<30 percent marrow blasts (former RAEB-t)
* CMML and other forms of mixed MDS/MPD
* IPSS and IPSS-R Risk group classification (mandatory)
* Able and willing to provide the written informed consent
Exclusion Criteria:
* Age \<18 years
* Patient unwilling or unable to give consent
* AML with ≥30 percent marrow blasts according to WHO
* Patients with inv(16), t(5;17) and t(8;21) are considered AML and therefore not eligible
* Patients with higher risk MDS progressed from a previously diagnosed lower risk MDS that was not registered within 100 days after first diagnosis of (lower risk) MDS
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00600860
Study Brief:
Protocol Section:
NCT00600860